We are conducting a research study, and your participation will help us better understand how patterns of mobility are related to the risk of COVID-19.
If you choose to participate, you will:
- If you have symptoms or tested positive for COVID-19, understand when and where you may have been infected.
Your contribution will help inform actionable plans to ease restrictions and safely re-open our communities. This will be especially important for protecting those who are most vulnerable.
The information you receive is not intended to be a substitute for professional advice on COVID-19. We encourage you to monitor publicly available information and to always follow federal, state and local health organization guidance and government mandates.
Our Team
“Information from the public is essential to learn more about the areas of risk and how we can prevent future outbreaks. We need to work with our communities to develop strategies to safely re-open and protect those who are most vulnerable.”
Yulin Hswen, ScD, MPH
- Assistant Professor of Epidemiology and Biostatistics
Director of the “Data Hub”, Bakar Computational Health Sciences Institute
University of California, San Francisco - Adjunct Faculty, Computational Epidemiology Lab
Harvard Medical School
“We have been doing a lot to control this pandemic and shelter-in-place and social distancing have brought case numbers down significantly, which is why they are critical. We need to use real data to get the kind of estimates we need to decide when and where to re-open, and how to do so safely.”
George Rutherford, MD
- Professor of Epidemiology,
University of California, San Francisco
“We must advocate for equitable distribution of safety. That means a focused investment in capturing information from those disproportionately affected by COVID-19.”
Kirsten Bibbins-Domingo, PhD, MD, MAS
- Lee Goldman, MD Endowed Chair in Medicine
- Professor and Chair of the Department of Epidemiology and Biostatistics,
University of California, San Francisco - Inaugural Vice Dean for Population Health and Health Equity,
UCSF School of Medicine
About COVIDSEEKER
Covidseeker is a research initiative comprised of a group of scientists, doctors, and epidemiologists working to understand how we can re-open our communities safely.
What do I need to do?
- Answer questions about your health and mobility (1 minute)
- Donate your location history (5 minutes)
Help promote Covidseeker by sharing on Twitter, Facebook, Instagram, or by email!
For help completing the survey, or if you have any questions, please contact yulin.hswen@ucsf.edu.
Protecting your privacy
All of the data collected for the Covidseeker research project follows strict practices to ensure your privacy. Read our complete privacy policy here.
The Covidseeker research initiative is led by a group of scientists, doctors, and epidemiologists at the University of California, San Francisco working to understand how we can re-open our communities safely and protect those who are most vulnerable.
Other Ongoing Research
UCSF Partnership to Guide State COVID-19 Response
A new long-term research collaboration between UCSF, Stanford University and the Chan Zuckerberg Biohub – with $13.6 million in funding from the Chan Zuckerberg Initiative – includes a major study led by investigator George Rutherford, MD. The team will sample a broad, representative population in the Bay Area to provide COVID infection data to inform policy decisions meant to maintain low transmission without undue restrictions while we await a vaccine.
Stalking New COVID-19 Infections Across California
George Rutherford, MD, will lead the $8.7-million state-funded UCSF Pandemic Workforce Training Academy, working with the California Department of Public Health to limit the ongoing spread of COVID-19. Based on a model UCSF developed with the San Francisco Department of Public Health, the Academy will facilitate the training of thousands of redeployed civil servants and volunteers in public health techniques and strategies, including contact tracing and case investigation. Dr. Rutherford will be working with colleagues at the University of California, Los Angeles.